BAY CITY CAPITAL FUND LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAY CITY CAPITAL FUND LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAY CITY CAPITAL FUND LLC. BAY CITY CAPITAL FUND LLC is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and 10% Owner in SUNESIS PHARMACEUTICALS INC ($SNSS) and in NEVRO CORP ($NVRO) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and 10% Owner in IMARA Inc. ($IMRA).
Latest Insider Trading Transactions of BAY CITY CAPITAL FUND LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EPZM, IMRA, ILIU, KZR, SNTA, NVRO, SNSS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 01 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 43,537 | 0 | 2,310,521 | 2.4 M to 2.3 M (-1.85 %) |
Dec 01 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 43,537 | 0 | 2,310,521 | 2.4 M to 2.3 M (-1.85 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 45,460 | 0 | 43,537 | 89 K to 43.5 K (-51.08 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 45,460 | 0 | 43,537 | 89 K to 43.5 K (-51.08 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 31,650 | 0 | 49,730 | 81.4 K to 49.7 K (-38.89 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 31,650 | 0 | 49,730 | 81.4 K to 49.7 K (-38.89 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 1,468,350 | 0 | 2,260,791 | 3.7 M to 2.3 M (-39.38 %) |
Sep 04 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 1,468,350 | 0 | 2,260,791 | 3.7 M to 2.3 M (-39.38 %) |
Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 107.64 | 7,303 | 786,095 | 42,875 | 50.2 K to 42.9 K (-14.55 %) |
Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 110.03 | 10,197 | 1,121,976 | 50,178 | 60.4 K to 50.2 K (-16.89 %) |
Aug 19 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 110.73 | 12,500 | 1,384,125 | 60,375 | 72.9 K to 60.4 K (-17.15 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 44,903 | 0 | 72,875 | 117.8 K to 72.9 K (-38.13 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 44,903 | 0 | 72,875 | 117.8 K to 72.9 K (-38.13 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 6,772 | 0 | 81,380 | 88.2 K to 81.4 K (-7.68 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 6,772 | 0 | 81,380 | 88.2 K to 81.4 K (-7.68 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 360,561 | 0 | 3,729,141 | 4.1 M to 3.7 M (-8.82 %) |
May 29 2020 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | J | 0.00 | 360,561 | 0 | 3,729,141 | 4.1 M to 3.7 M (-8.82 %) |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | A | 16.00 | 15,457 | 247,312 | 15,457 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 16,103 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 845,008 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 61,378 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 3,220,915 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 5,372 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 281,878 | 0 | 0 | |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 13,148 | 0 | 703,380 | 690.2 K to 703.4 K (+1.90 %) |
Mar 16 2020 | IMRA | IMARA Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 690,232 | 0 | 690,232 | 0 to 690.2 K |
Dec 13 2019 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 105.47 | 25,320 | 2,670,500 | 88,152 | 113.5 K to 88.2 K (-22.31 %) |
Dec 13 2019 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 105.47 | 1,174,680 | 123,893,500 | 4,089,702 | 5.3 M to 4.1 M (-22.31 %) |
Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 472,229 | 0 | 0 | |
Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 15.00 | 150,000 | 2,250,000 | 622,229 | 472.2 K to 622.2 K (+31.76 %) |
Jun 28 2018 | KZR | Kezar Life Science ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 472,229 | 0 | 472,229 | 0 to 472.2 K |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | Director | Sell | S | 287.46 | 5,908 | 1,698,314 | 113,472 | 119.4 K to 113.5 K (-4.95 %) |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | Director | Sell | S | 287.46 | 5,908 | 1,698,314 | 113,472 | 119.4 K to 113.5 K (-4.95 %) |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | Director | Sell | S | 287.46 | 274,092 | 78,790,486 | 5,264,382 | 5.5 M to 5.3 M (-4.95 %) |
Jun 12 2018 | SNTA | MADRIGAL PHARMACEU ... | BAY CITY CAPITAL LLC | Director | Sell | S | 287.46 | 274,092 | 78,790,486 | 5,264,382 | 5.5 M to 5.3 M (-4.95 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 564,386 | 56,100 | 564,386 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.10 | 29,616,700 | 2,943,900 | 29,616,700 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 564,386 | 56,100 | 1,444,485 | 880.1 K to 1.4 M (+64.13 %) |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.10 | 29,616,700 | 2,943,900 | 75,800,716 | 46.2 M to 75.8 M (+64.13 %) |
Jan 12 2016 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 9.00 | 10,389 | 93,501 | 3,380,951 | 3.4 M to 3.4 M (+0.31 %) |
Jan 12 2016 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 9.00 | 545,166 | 4,906,494 | 3,370,562 | 2.8 M to 3.4 M (+19.30 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 10,383 | 13,706 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 20,766 | 27,411 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 544,893 | 719,259 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | X | 1.32 | 1,089,788 | 1,438,520 | 0 | |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 3,962 | 13,709 | 5,623,815 | 5.6 M to 5.6 M (-0.07 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 10,383 | 13,706 | 5,627,777 | 5.6 M to 5.6 M (+0.18 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 7,925 | 27,421 | 5,617,394 | 5.6 M to 5.6 M (-0.14 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 20,766 | 27,411 | 5,625,319 | 5.6 M to 5.6 M (+0.37 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 207,938 | 719,465 | 5,604,553 | 5.8 M to 5.6 M (-3.58 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 544,893 | 719,259 | 5,812,491 | 5.3 M to 5.8 M (+10.34 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 3.46 | 415,877 | 1,438,934 | 5,267,598 | 5.7 M to 5.3 M (-7.32 %) |
Jul 28 2015 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | X | 1.32 | 1,089,788 | 1,438,520 | 5,683,475 | 4.6 M to 5.7 M (+23.72 %) |
Jun 17 2015 | NVRO | NEVRO CORP | BAY CITY CAPITAL LLC | Sell | S | 47.94 | 10,378 | 497,521 | 36,403 | 46.8 K to 36.4 K (-22.18 %) | |
Jun 17 2015 | NVRO | NEVRO CORP | BAY CITY CAPITAL LLC | Sell | S | 47.94 | 481,457 | 23,081,049 | 1,688,976 | 2.2 M to 1.7 M (-22.18 %) |
Page: 1